EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of antimicrobial resistance in Campylobacter spp. and Salmonella spp. in Switzerland 2007–2022: a retrospective observational study

Frederik Jung, Deborah R. Vogt, Roger Stephan, Andreas Kronenberg, Adrian Egli, the Swiss Antibiotic Resistance Centre ANRESIS

Swiss Medical Weekly · 30.10.2026 · 156 (10) · 4615

DOI: 10.57187/4615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Swiss Medical Weekly, online erschienen am 30.10.2026. Verfasst von Frederik Jung und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In Switzerland, acute infectious diarrhoea is frequently caused by Campylobacter spp. and Salmonella spp. The rise of antimicrobial resistance complicates treatment and underscores requirements for continuous surveillance. We aimed to analyse the development of antimicrobial resistance in Campylobacter spp. and Salmonella spp. isolated from human samples in Switzerland over time. METHODS: We conducted a retrospective observational analysis using the ANRESIS database, covering the period from January 2007 to December 2022. The study included 47,498 Campylobacter spp. isolates and 5964 Salmonella enterica isolates. Antimicrobial resistance was categorised according to CLSI or EUCAST. Descriptive statistical analyses were performed to explore resistance over time, focusing on pathogens and invasive versus non-invasive isolates. RESULTS: The majority of Campylobacter isolates were Campylobacter jejuni (80.4%) and Campylobacter coli (7%). Resistance to ciprofloxacin in Campylobacter jejuni increased from 38% in 2007 to 81% in 2022. Resistance to doxycycline and tetracycline also rose sharply between 2012 and 2014, reaching approximately 37% by 2022. Resistance to macrolides remained consistently low (

Zitieren

APA

Jung, F., Vogt, D. R., Stephan, R., Kronenberg, A., Egli, A., & ANRESIS, T. S. A. R. C. (2026). Prevalence of antimicrobial resistance in Campylobacter spp. and Salmonella spp. in Switzerland 2007–2022: a retrospective observational study. Swiss Medical Weekly, 156(10), 4615. https://doi.org/10.57187/4615

Vancouver

Jung F, Vogt DR, Stephan R, Kronenberg A, Egli A, ANRESIS TSARC. Prevalence of antimicrobial resistance in Campylobacter spp. and Salmonella spp. in Switzerland 2007–2022: a retrospective observational study. Swiss Medical Weekly. 2026;156(10):4615. doi:10.57187/4615

BibTeX
@article{Jung2026,
  author = {Jung, Frederik and Vogt, Deborah R. and Stephan, Roger and Kronenberg, Andreas and Egli, Adrian and ANRESIS, the Swiss Antibiotic Resistance Centre},
  title = {Prevalence of antimicrobial resistance in Campylobacter spp. and Salmonella spp. in Switzerland 2007–2022: a retrospective observational study},
  journal = {Swiss Medical Weekly},
  year = {2026},
  volume = {156},
  number = {10},
  pages = {4615},
  doi = {10.57187/4615}
}
Kostenlos starten →